BEAM:NASDAQ
Beam Therapeutics Inc
၂၀.၉၀ US$
arrow_downward
-၀.၁၉%(-၀.၀၄၀) 1D
၂၁.၆၆ US$
arrow_upward
+၃.၆၅% (+၀.၇၆)bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
၂၀.၆၀ US$
High
၂၂.၁၀ US$
Low
၂၀.၅၄ US$
Mkt. cap
၂၁၆.၃၁ ဋေ
Avg. vol.
၂.၁၆ သန်း
Volume
၃.၈၉ သန်း
52-wk high
၃၈.၂၆ US$
52-wk low
၂၀.၃၉ US$
EPS
-၁.၀၀ US$
Beta
၂.၂၃
Shares outstanding
၁၀.၃၅ ကုဋေ
No. of employees
၅၅၇
Open
၂၀.၆၀ US$
High
၂၂.၁၀ US$
Low
၂၀.၅၄ US$
Mkt. cap
၂၁၆.၃၁ ဋေ
Avg. vol.
၂.၁၆ သန်း
Volume
၃.၈၉ သန်း
52-wk high
၃၈.၂၆ US$
52-wk low
၂၀.၃၉ US$
EPS
-၁.၀၀ US$
Beta
၂.၂၃
Shares outstanding
၁၀.၃၅ ကုဋေ
No. of employees
၅၅၇
News stories
From web sources and news partners
Traders Union
·
ပြီးခဲ့သည့် ၁ နာရီ
A 12% S&P 500 drop matches UK and German markets going to zero, Howard Lindzon notes
Benzinga
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
Dow Jones and S&P 500 Outlook: Top Stock Market Headlines and Data This Week
Wisevoter
·
ပြီးခဲ့သည့် ၅၁ မိနစ်
S&P 500 and Dow Slide Into Correction
StoneX
·
ပြီးခဲ့သည့် ၂ ရက်
S&P 500, Nasdaq 100 Drive into Correction Territory
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc